Melanoma Clinical Trials

Showing 1061-1080 of 1,477 trials

Training Primary Care Physicians to Perform Melanoma Opportunistic Surveillance

NCT02385253

This is a four-phase educational intervention for primary care practitioners (PCPs) to perform opportunistic melanoma surveillance. Based on prior research, the investigator will develop an interactive melanoma early detection skills training program for PCPs according to the principals of mastery learning. The proposed educational intervention will improve practicing PCPs' knowledge, competence, confidence, and diagnostic performance regarding pigmented lesions and attitude concerning importance of skin surveillance. In addition, this research aims to examine the clinical proficiency of PCPs regarding pigmented lesions. The proposed educational intervention will reduce the percentage of benign lesions referred to dermatology.

MelanomaNeviSkin Moles

Northwestern University89 participantsStarted Sep 2015

Chicago, Illinois, United States • Chicago, Illinois, United States

COMPLETEDPhase 2

A Study of Tasisulam in Treating Participants With Malignant Melanoma

NCT00383292

The primary purpose of this study is to determine the objective response rate (complete and partial response) for participants who receive tasisulam after one prior systemic treatment for unresectable or metastatic melanoma.

Metastatic Melanoma

Eli Lilly and Company130 participantsStarted Nov 2006

Los Angeles, California, United States • Aurora, Colorado, United States • Lakeland, Florida, United States +10 more locations

Training Primary Care Physicians to Perform Melanoma Opportunistic Surveillance

A Study of Tasisulam in Treating Participants With Malignant Melanoma

Related Searches

Feasibility Study of Genomic Profiling Methods and Timing in Tumor Samples

ML29255 Neoadjuvant Vemurafenib and Cobimetinib Melanoma

Evaluation of the Immunogenicity of Vaccination With Multiple Synthetic Melanoma Peptides With Granulocyte-macrophage Colony-stimulating Factor (GM-CSF)-In-Adjuvant, in Patients With Advanced Melanoma

Bevacizumab and Temozolomide or Bevacizumab and Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin in Treating Patients With Stage IV Malignant Melanoma That Cannot Be Removed by Surgery

Effectiveness, Safety and Use of Nivolumab Administered During the French Temporary Authorization for Use in Patients With Advanced Melanoma

Diagnosing Melanoma, Squamous Cell Carcinoma and Basal Cell Carcinoma Using the Spectra-Scope

The Effectiveness of Nivolumab Monotherapy as First-Line Therapy in Adults With Advanced Melanoma in Germany

Dacarbazine and Carmustine in Metastatic Melanoma

Second Echelon Node Study With Methylene Blue

A Sunscreen Based on Bioadhesive Nanoparticles

Prospective, RCT of Split Thickness Skin Grafts on Lower Leg After Compression Therapy With Compression Bandage vs. NPWT

Universal Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)-Producing and CD40L Expressing Bystander Cell Line for Tumor Vaccine in Melanoma

Can We Miss Pigmented Lesions in Psoriasis Patients?

Phase II Randomized Trial of Ipilimumab Versus Ipilimumab and Radiotherapy in Metastatic Melanoma

Anonymous Testing of Pathology Specimens for BRCA Mutations in Ashkenazi Jewish Individuals Who Have Cancer

Survival Study for Participants Treated With Ipilimumab-Nivolumab Combination Therapy

HDI Versus Chemotherapy as Systemic Adjuvant Therapy for Resected Mucosal Melanoma

Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma